OBJECTIVE: 20-Hydroxyeicosatetraenoic acid (20-HETE), a [omega]-hydroxylation product of arachidonic acid catalyzed by cytochrome P450 4A, may play a role in the cardiovascular system. It is well known that cytochrome P450 [omega]-hydroxylase inhibitors markedly reduced the cardiac ischemia reperfusion injury. However, the direct effect of 20-HETE on cardiomyocytes is still poorly investigated. Here, we studied the effect of 20-HETE on cardiomyocyte apoptosis and the apoptosis-associated signaling pathways. METHODS AND RESULTS: The cardiomyocyte apoptosis was measured by fluorescein isothiocyanate conjugated annexin V/propidium iodide double staining cytometry, indicating that the percentage of early apoptotic cells increased from 15.6% +/- 2.6% to 25.5% +/- 2.5% in control and 20-HETE-treated cells, respectively. The mitochondrial membrane potential ([DELTA][PSI]m) was measured by detecting the ratio of JC-1 green/red emission intensity. A significant decrease in the ratio was observed after treatment with 20-HETE for 24 hours in comparison with control group, suggesting the disruptive effect of 20-HETE on mitochondrial [DELTA][PSI]m. In addition, 20-HETE stimulated caspase-3 activity and Bax mRNA expression in cardiomyocytes. In contrast, the Bcl-2 mRNA levels were significantly decreased by 20-HETE treatment. CONCLUSION: These results demonstrate that 20-HETE induces cardiomyocyte apoptosis by activation of several intrinsic apoptotic pathways. The 20-HETE-induced apoptosis could contribute to the cytochrome P450 [omega]-hydroxylase-dependent cardiac injure during cardiac ischemia-reperfusion.
OBJECTIVE:20-Hydroxyeicosatetraenoic acid (20-HETE), a [omega]-hydroxylation product of arachidonic acid catalyzed by cytochrome P450 4A, may play a role in the cardiovascular system. It is well known that cytochrome P450 [omega]-hydroxylase inhibitors markedly reduced the cardiac ischemia reperfusion injury. However, the direct effect of 20-HETE on cardiomyocytes is still poorly investigated. Here, we studied the effect of 20-HETE on cardiomyocyte apoptosis and the apoptosis-associated signaling pathways. METHODS AND RESULTS: The cardiomyocyte apoptosis was measured by fluorescein isothiocyanate conjugated annexin V/propidium iodide double staining cytometry, indicating that the percentage of early apoptotic cells increased from 15.6% +/- 2.6% to 25.5% +/- 2.5% in control and 20-HETE-treated cells, respectively. The mitochondrial membrane potential ([DELTA][PSI]m) was measured by detecting the ratio of JC-1 green/red emission intensity. A significant decrease in the ratio was observed after treatment with 20-HETE for 24 hours in comparison with control group, suggesting the disruptive effect of 20-HETE on mitochondrial [DELTA][PSI]m. In addition, 20-HETE stimulated caspase-3 activity and Bax mRNA expression in cardiomyocytes. In contrast, the Bcl-2 mRNA levels were significantly decreased by 20-HETE treatment. CONCLUSION: These results demonstrate that 20-HETE induces cardiomyocyte apoptosis by activation of several intrinsic apoptotic pathways. The 20-HETE-induced apoptosis could contribute to the cytochrome P450 [omega]-hydroxylase-dependent cardiac injure during cardiac ischemia-reperfusion.
Authors: Kasem Nithipatikom; Eric R Gross; Michael P Endsley; Jeannine M Moore; Marilyn A Isbell; John R Falck; William B Campbell; Garrett J Gross Journal: Circ Res Date: 2004-09-23 Impact factor: 17.367
Authors: B Freude; T N Masters; F Robicsek; A Fokin; S Kostin; R Zimmermann; C Ullmann; S Lorenz-Meyer; J Schaper Journal: J Mol Cell Cardiol Date: 2000-02 Impact factor: 5.000
Authors: Franz Kehl; Liana Cambj-Sapunar; Kristopher G Maier; Noriyuki Miyata; Shunishi Kametani; Hirotsugu Okamoto; Anthony G Hudetz; Marie L Schulte; Drazen Zagorac; David R Harder; Richard J Roman Journal: Am J Physiol Heart Circ Physiol Date: 2002-04 Impact factor: 4.733
Authors: David J Granville; Babak Tashakkor; Cindy Takeuchi; Asa B Gustafsson; Chengqun Huang; M Richard Sayen; Paul Wentworth; Mark Yeager; Roberta A Gottlieb Journal: Proc Natl Acad Sci U S A Date: 2004-01-20 Impact factor: 11.205
Authors: S A Susin; E Daugas; L Ravagnan; K Samejima; N Zamzami; M Loeffler; P Costantini; K F Ferri; T Irinopoulou; M C Prévost; G Brothers; T W Mak; J Penninger; W C Earnshaw; G Kroemer Journal: J Exp Med Date: 2000-08-21 Impact factor: 14.307
Authors: James P Hardwick; Katie Eckman; Yoon Kwang Lee; Mohamed A Abdelmegeed; Andrew Esterle; William M Chilian; John Y Chiang; Byoung-Joon Song Journal: Adv Pharmacol Date: 2013
Authors: Marija Renic; Suresh N Kumar; Debebe Gebremedhin; Matthew A Florence; Nashaat Z Gerges; John R Falck; David R Harder; Richard J Roman Journal: Am J Physiol Heart Circ Physiol Date: 2012-01-13 Impact factor: 4.733
Authors: Fan Fan; Ying Ge; Wenshan Lv; Matthew R Elliott; Yoshikazu Muroya; Takashi Hirata; George W Booz; Richard J Roman Journal: Front Biosci (Landmark Ed) Date: 2016-06-01